Growth Metrics

Utah Medical Products (UTMD) Cost of Revenue (2016 - 2025)

Historic Cost of Revenue for Utah Medical Products (UTMD) over the last 16 years, with Q3 2025 value amounting to $4.2 million.

  • Utah Medical Products' Cost of Revenue rose 11.9% to $4.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.6 million, marking a year-over-year decrease of 873.4%. This contributed to the annual value of $16.8 million for FY2024, which is 1697.22% down from last year.
  • Latest data reveals that Utah Medical Products reported Cost of Revenue of $4.2 million as of Q3 2025, which was up 11.9% from $4.4 million recorded in Q2 2025.
  • Over the past 5 years, Utah Medical Products' Cost of Revenue peaked at $5.3 million during Q2 2022, and registered a low of $3.8 million during Q4 2024.
  • In the last 5 years, Utah Medical Products' Cost of Revenue had a median value of $4.7 million in 2023 and averaged $4.6 million.
  • As far as peak fluctuations go, Utah Medical Products' Cost of Revenue skyrocketed by 2559.29% in 2021, and later crashed by 2674.31% in 2024.
  • Over the past 5 years, Utah Medical Products' Cost of Revenue (Quarter) stood at $4.8 million in 2021, then grew by 9.29% to $5.2 million in 2022, then dropped by 0.23% to $5.2 million in 2023, then decreased by 26.74% to $3.8 million in 2024, then increased by 9.73% to $4.2 million in 2025.
  • Its Cost of Revenue was $4.2 million in Q3 2025, compared to $4.4 million in Q2 2025 and $4.2 million in Q1 2025.